Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2026-01-01 @ 11:05 AM
Study NCT ID:
NCT03376932
Status:
WITHDRAWN
Last Update Posted:
2019-03-25
First Post:
2017-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-02-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-02-03
Completion Date Type:
ESTIMATED
First Submit Date:
2017-12-01
First Submit QC Date:
None
Study First Post Date:
2017-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-22
Last Update Post Date:
2019-03-25
Last Update Post Date Type:
ACTUAL